TheraVida's Unattributed Round

TheraVida raised a round of funding on November 28, 2009. Investors include Sanderling Ventures.

TheraVida is developing a combination drug product platform, with the potenial to significantly improve existing therapies for a variety of diseases. The company is currently focusing its efforts on t…

Articles about TheraVida's Unattributed Round: